(Q73299019)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10609532%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Stavudine, lamivudine and indinavir in drug abusing and non-drug abusing HIV-infected patients: adherence, side effects and efficacy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10609532%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

1 reference

1 reference

B Roca

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10609532%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

C J Gómez

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10609532%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A Arnedo

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10609532%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 September 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10609532%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10609532%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10609532%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10609532%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

141-145

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10609532%20AND%20SRC:MED&resulttype=core&format=json

Self-reported antiretroviral therapy in injection drug users.

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2899%2990006-3

7 January 2021

Barriers to use of free antiretroviral therapy in injection drug users.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2899%2990006-3

7 January 2021

Longer survival after HIV infection for injecting drug users than for homosexual men: implications for immunology.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2899%2990006-3

7 January 2021

Comparison of progression and non-progression in injecting drug users and homosexual men with documented dates of HIV-1 seroconversion. European Seroconverter Study and the Tricontinental Seroconverter Study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2899%2990006-3

7 January 2021

Race, Sex, Drug Use, and Progression of Human Immunodeficiency Virus Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2899%2990006-3

7 January 2021

Adherence and antiretroviral therapy in injection drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2899%2990006-3

7 January 2021

Rethinking nonadherence: historical perspectives on triple-drug therapy for HIV disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2899%2990006-3

7 January 2021

Adherence to complex combination antiretroviral therapies by HIV-positive drug abusers

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2899%2990006-3

7 January 2021

Predictors of long-term response to protease inhibitor therapy in a cohort of HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2899%2990006-3

7 January 2021

Potential factors affecting adherence with HIV therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2899%2990006-3

7 January 2021

Public Health Implications of Antiretroviral Therapy and HIV Drug Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2899%2990006-3

7 January 2021

Adherence and effectiveness of highly active antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2899%2990006-3

7 January 2021

The era of adherence to HIV therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2899%2990006-3

7 January 2021

Medication therapy among intravenous drug users (IDUs) with HIV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2899%2990006-3

7 January 2021

Urolithiasis associated with the protease inhibitor indinavir

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2899%2990006-3

7 January 2021

Disorders of fat distribution in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2899%2990006-3

7 January 2021

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2899%2990006-3

7 January 2021

Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2899%2990006-3

7 January 2021

10.1016/S0163-4453(99)90006-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10609532%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference